Prasol Chemicals Limited is set to enter the Indian primary market with a ₹500 crore mainboard IPO. The Maharashtra-based speciality chemicals manufacturer has fixed the price band at ₹643 to ₹676 per equity share, with the issue scheduled to open on September 8, 2026 and close on September 10, 2026. The IPO comprises a fresh issue of ₹80 crore and an offer for sale of up to ₹420 crore by promoters and existing shareholders.
Prasol Chemicals IPO Details
| Particular | Details |
|---|---|
| Company | Prasol Chemicals Limited |
| IPO Type | Mainboard IPO |
| Issue Type | Book-Built Issue |
| IPO Open Date | September 8, 2026 |
| IPO Close Date | September 10, 2026 |
| Price Band | ₹643 – ₹676 per share |
| Face Value | ₹2 per share |
| Total Issue Size | ₹500 crore |
| Fresh Issue | ₹80 crore |
| Offer for Sale | ₹420 crore |
| Total Shares Offered | Approximately 73.96 lakh shares |
| Lot Size | 22 shares |
| Minimum Investment | ₹14,872 |
| Anchor Investor Date | September 7, 2026 |
| Basis of Allotment | September 11, 2026 |
| Refund Initiation | September 15, 2026 |
| Credit of Shares | September 15, 2026 |
| Listing Date | September 16, 2026 |
| Listing Exchanges | BSE and NSE |
| QIB Reservation | Not more than 50% |
| NII Reservation | Not less than 15% |
| Retail Reservation | Not less than 35% |
| Lead Managers | JM Financial; DAM Capital Advisors |
| Registrar | KFin Technologies |
The minimum application is one lot of 22 shares. At the upper price band of ₹676, retail investors need ₹14,872 for one lot. The anchor bidding is scheduled for September 7, followed by the public issue from September 8 to September 10. Allotment is expected on September 11, refunds and share credit are scheduled for September 15, and listing is expected on September 16 on BSE and NSE.
What Does Prasol Chemicals Do?
Prasol Chemicals is a speciality chemicals manufacturer that has been operating since 1992. The company produces acetone-based, phosphorus-based and other customised speciality chemicals used across industries including pharmaceuticals, agrochemicals, paints, inks, construction, adhesives, home and personal care and performance chemicals. As of June 30, 2026, its portfolio included more than 150 products across these categories.
The company follows a forward-integrated manufacturing model and operates two manufacturing facilities in Maharashtra. Its products include surfactants, performance additives, ethers, esters, polymers, acids and other differentiated chemical products. Prasol served more than 1,600 customers across 69 countries as of July 15, 2026, giving it both domestic and international exposure.
Also Read: Rentomojo IPO 2026: Price, Dates, GMP, Financials & Key Risks
The company’s customer base spans multiple end-use industries, which provides some diversification compared with a chemical manufacturer dependent on a single sector. Its export operations also provide access to international markets, although exports and imported raw materials introduce currency, logistics and global-demand considerations.
Prasol Chemicals Manufacturing Capabilities
Prasol Chemicals operates manufacturing facilities at Khopoli and Mahad in Maharashtra, with aggregate installed capacity of approximately 98,644 metric tonnes per annum. The company manufactures a broad portfolio of speciality chemicals, including acetone and phosphorus derivatives as well as customised products.
Its product portfolio serves industries where chemical performance, formulation requirements and product consistency are important. The company also has research and development capabilities, with products under development that could support future portfolio expansion.
The manufacturing footprint provides Prasol with an established production base, but capacity utilisation remains an important factor. The Mahad facility, in particular, has experienced relatively low utilisation, which means the company needs to improve capacity utilisation and operating efficiency to extract better returns from its existing assets.
Also Read: Manipal Payment & Identity Solutions IPO 2026: Price, Dates, GMP, Financials & Key Risks
How Will Prasol Chemicals Use IPO Funds?
The ₹80 crore fresh issue is intended primarily to strengthen the company’s balance sheet. Approximately ₹60 crore of the proceeds will be used for repayment or prepayment of borrowings, while the remaining amount is intended for general corporate purposes. The company had outstanding indebtedness of approximately ₹343.7 crore as of July 15, 2026.
Debt reduction is an important component of the IPO because it could reduce the company’s interest burden and improve financial flexibility. However, the fresh issue represents only 16% of the total ₹500 crore IPO, while approximately 84% is an OFS.
The OFS proceeds will go to the selling shareholders rather than to Prasol Chemicals. Therefore, investors should distinguish between the ₹500 crore headline issue size and the ₹80 crore of fresh capital that will actually strengthen the company’s balance sheet.
Prasol Chemicals Financial Performance
Prasol Chemicals has recorded strong growth in revenue and profitability over the last three financial years. Restated revenue increased from approximately ₹887.56 crore in FY24 to ₹1,015.54 crore in FY25 and ₹1,237.85 crore in FY26. Profit after tax increased from ₹18.13 crore in FY24 to ₹43.57 crore in FY25 and further to ₹83.12 crore in FY26.
Also Read: Steamhouse India IPO 2026: Price, Dates, GMP, Financials & Key Risks
EBITDA increased from ₹60.53 crore in FY24 to ₹87.77 crore in FY25 and ₹139.32 crore in FY26. The company’s FY26 EBITDA margin was approximately 11.30%, while PAT margin stood at around 6.74%.
The improvement in profitability is particularly notable because PAT more than doubled between FY25 and FY26. Diluted EPS reached ₹14.33 in FY26 compared with ₹7.51 in FY25 and ₹3.13 in FY24. Net worth stood at approximately ₹448.51 crore at the end of FY26.
Operating cash flow was approximately ₹49.47 crore in FY26, compared with ₹22.26 crore in FY25. This indicates improvement in cash generation, although the company’s working-capital requirements and fluctuations in operating cash flow remain important factors for investors to monitor.
Prasol Chemicals Export Presence
International business is an important part of Prasol Chemicals’ growth strategy. The company exports its products to 69 countries across six continents and holds a Government of India 3 Star Export House certification. It has also obtained regulatory registrations for certain products in international markets.
Also Read: LCC Projects IPO 2026: Price, Dates, GMP, Financials & Key Risks
Exports accounted for approximately 27.29% of revenue in FY26 according to available offer-document analysis. This international exposure provides diversification beyond India’s domestic chemical market and creates opportunities to serve global customers.
However, international operations also expose the company to foreign-exchange movements, overseas regulatory requirements, global demand conditions, shipping costs and geopolitical or trade-related disruptions. These factors can influence both revenue and margins.
Prasol Chemicals Customer Base
Customer diversification is one of the relatively positive aspects of the business. The company served approximately 1,618 customers in FY26, while its top 10 customers accounted for around 23.68% of revenue. This means the business is not overwhelmingly dependent on a small number of customers.
Its customers include companies operating in pharmaceuticals, agrochemicals, chemicals, consumer products and other industries. The diversified end-market exposure can help reduce dependence on any single industry, although demand for Prasol’s products ultimately remains linked to the performance of its customers and the end products in which its chemicals are used.
Also Read: Karamtara Engineering IPO 2026: Price, Dates, GMP, Financials & Key Risks
Prasol Chemicals IPO Valuation
At the upper price band of ₹676, Prasol Chemicals is valued at approximately ₹4,000.8 crore. Based on FY26 diluted EPS of ₹14.33, the valuation implies a P/E multiple of roughly 47 times FY26 earnings.
This valuation is an important consideration because the company’s P/E multiple is at a premium to the average valuation of its listed industry peers, according to the risk disclosures and offer-document analysis. Investors therefore need to assess whether the company’s recent earnings growth can continue strongly enough to justify the valuation.
The valuation case is supported by strong revenue and profit growth, a broad speciality-chemical portfolio, international presence and customer diversification. On the other hand, the high valuation, significant OFS component and chemical-industry risks mean that investors should avoid evaluating the IPO purely on recent earnings growth.
Key Risks in Prasol Chemicals IPO
One of the key risks is the company’s dependence on manufacturing facilities. Prasol’s operations are concentrated across two facilities in Maharashtra, and any prolonged shutdown, operational disruption or under-utilisation could affect production, revenue and profitability. The Mahad facility has previously experienced operational disruption and continued low utilisation remains a factor investors should monitor.
Also Read: Glass Wall Systems (India) IPO Details: Price, Dates, Financials, GMP and Key Risks
Raw-material costs are another important risk. Specialty chemicals require various raw materials, and a significant portion of Prasol’s raw-material procurement is sourced from imports. Approximately 65.96% of raw-material procurement was imported according to available offer-document analysis. This creates exposure to foreign exchange, international prices, freight costs and supply-chain disruptions.
The chemical industry also faces regulatory and environmental risks. Manufacturing facilities require various approvals, licences and permits, and any failure to obtain, renew or maintain them could affect operations. Environmental incidents, safety issues or regulatory changes could result in additional costs or operational interruptions.
Debt remains another consideration. Although the IPO proposes to use ₹60 crore to reduce borrowings, total outstanding indebtedness was approximately ₹343.67 crore as of July 15, 2026. The company’s ability to manage debt while funding working capital and maintaining manufacturing operations will remain important.
The company’s earnings are also linked to the demand for products manufactured by its customers. A slowdown in pharmaceuticals, agrochemicals, paints, construction, consumer products or other end-user industries could reduce demand for Prasol’s chemicals.
Also Read: Asset Reconstruction Company (India) IPO Details: Price, Dates, Financials, GMP and Key Risks
Finally, valuation risk cannot be ignored. At the upper price band, the company is being offered at a relatively high earnings multiple. If future earnings growth slows or margins decline, the premium valuation could place pressure on the stock after listing.
Prasol Chemicals IPO: What Investors Should Watch
Prasol Chemicals enters the IPO market with a combination of strong recent financial growth, a diversified speciality-chemical portfolio, international exposure and a large customer base. Revenue has increased substantially over the past three years, while PAT has grown from ₹18.13 crore in FY24 to ₹83.12 crore in FY26.
The proposed use of ₹60 crore toward debt repayment is another positive factor because it could reduce financial pressure. However, the IPO is heavily weighted toward an OFS, with ₹420 crore of the ₹500 crore issue coming from existing shareholders. The company itself receives only the fresh issue proceeds.
Investors should therefore focus on whether Prasol can sustain its recent earnings growth, improve utilisation at its manufacturing facilities, manage imported raw-material exposure and generate stronger operating cash flows. The valuation at the upper price band also leaves less room for disappointment if growth moderates.
Also Read: Kanohar Electricals IPO Details: Price, Dates, Financials, GMP and Key Risks
Overall, Prasol Chemicals IPO offers exposure to India’s speciality chemicals sector through a company with improving financial performance and international reach. At the same time, investors should carefully weigh the premium valuation, debt position, facility utilisation, raw-material risks, regulatory requirements and OFS-heavy structure before making an investment decision.
Disclaimer: This article is for informational and educational purposes only and should not be considered investment advice or a recommendation to buy or subscribe to the Prasol Chemicals IPO. IPO dates, pricing, GMP and other market-related information may change. Investors should conduct their own research and carefully review the company’s offer documents, financial statements and risk factors before making any investment decision.
Also Read: Pranav Constructions IPO 2026: Complete Details, Price, Financials, Valuation & Risks
